During our recent live webinar, David Ziedman (SVP Global Accounts) and Jason Cunningham (Senior Consultant) explored how omnichannel offers an untapped opportunity for pharma to connect with Payers more effectively. Key topics included: • Achieving the most impactful channel mix for this target group • How does pharma’s digital offering compare to what Payers actually want? • Channels used by Payers with the highest reach, impact and frequency (with insights from the recently launched Navigator365™ Payer) • How benchmarking can tell us which companies are performing well (and not so well) in Omnichannel Watch the recorded webinar and access the full deck here: http://bit.ly/3VpujQH

1. Proprietary and confidential information
© Across Health
1
25/11/2022
1
Omnichannel for Payers:
A big opportunity for pharma
November 16th, 2022
Watch our recorded webinar or get access to the full slide deck >

2. Proprietary and confidential information
© Across Health
2
25/11/2022
Proprietary and confidential information
© Across Health
2
25/11/2022
2. What are the Omnichannel opportunities for Pharma to better
serve and impact Payers?
3. Which online (digital) and offline (traditional F2F) channels will support
improvement of overall reach and impact within your Omnichannel plan?
4. Which services and resources do Payers want and in which way do
they want it?
5. When and how do Payers want support for upcoming launches?
6. Where can you improve compared to your competitors on overall
Cx as well as at channel level?
1. What are the trends impacting on Payers?
The questions we will address in this webinar…

3. Proprietary and confidential information
© Across Health
3
25/11/2022
Proprietary and confidential information 3
© Across Health
25/11/2022
1.
What are the trends
impacting on Payers?

4. Proprietary and confidential information
© Across Health
4
25/11/2022
Omnichannel for payers needs to take into account all these trends to ensure success
COVID-19
MULTI-STAKEHOLDER
OMNICHANNEL VS
TRADITIONAL
INFORMATION
OVERLOAD
Learn more about Navigator365™ Payer

5. Proprietary and confidential information
© Across Health
5
25/11/2022
Proprietary and confidential information
© Across Health
5
25/11/2022
Source:
Digital channels are important to Payers: 62% rate them as important
Learn more about Navigator365™ Payer

6. Proprietary and confidential information
© Across Health
6
25/11/2022
13/07/2022
85 © Across Health Proprietary and Confidential
Information
Imagine an oncologist evaluating a lung cancer patient...
THEN:
disease type was defined by morphology
and treatments were limited to surgery or
cytotoxic therapy
NOW:
she has to understand a range of molecular
profiles and an ever-expanding range of
targeted therapies
How can physicians keep up with
the knowledge explosion
in medicine?

7. Proprietary and confidential information
© Across Health
7
25/11/2022
Proprietary and confidential information 7
© Across Health
25/11/2022
2.
What are the
Omnichannel opportunities
for Pharma to better serve
and impact Payers?

8. Proprietary and confidential information
© Across Health
8
25/11/2022
Proprietary and confidential information
© Across Health
8
25/11/2022
Source:
We cover the reach, impact and frequency of over 50 channels across Promo, Medical, Paid and
Earned

9. 25/11/2022
Proprietary and Confidential Information
© Across Health
9
Proprietary and confidential information
© Across Health
9
25/11/2022
Source:
Today we will cover some highlights from the four Parts of the Navigator365 Payer insights
Learn more about Navigator365™ Payer

10. 25/11/2022
Proprietary and Confidential Information
© Across Health
10
Proprietary and confidential information
© Across Health
10
25/11/2022
Source:
We can see some medical channels having high impact, while other promo and medical channels
offer higher reach with still decent impact

11. 25/11/2022
Proprietary and Confidential Information
© Across Health
11
Proprietary and confidential information 11
© Across Health
25/11/2022
3.
Which online (digital)
and offline (traditional F2F) channels
will support improvement of overall
reach and impact within your
Omnichannel plan?

12. 25/11/2022
Proprietary and Confidential Information
© Across Health
12
Proprietary and confidential information
© Across Health
12
25/11/2022
Source:
To compare impact- of channels, we apply the MultiChannel eQuivalent (MCQ) approach
Learn more about Navigator365™ Payer

13. 25/11/2022
Proprietary and Confidential Information
© Across Health
13
Proprietary and confidential information 13
© Across Health
25/11/2022
4.
Which services and resources
do Payers want
and in which way
do they want it?

14. 25/11/2022
Proprietary and Confidential Information
© Across Health
14
Proprietary and confidential information
© Across Health
14
25/11/2022
Source:
Self-service portals supported by content and services rated as highest
importance when it comes to digital channels
Learn more about Navigator365™ Payer

15. 25/11/2022
Proprietary and Confidential Information
© Across Health
15
Proprietary and confidential information 15
© Across Health
25/11/2022
5.
When and how
do Payers want support
for upcoming launches?

16. 25/11/2022
Proprietary and Confidential Information
© Across Health
16
Proprietary and confidential information
© Across Health
16
25/11/2022
Source:
When it comes to the market access AM and launch, a mix of F2F remote and
email is desired
45%
Specialists
16%
Specialists
3%
Specialists
Learn more about Navigator365™ Payer

17. 25/11/2022
Proprietary and Confidential Information
© Across Health
17
Proprietary and confidential information 17
© Across Health
25/11/2022
6.
Where can you improve
compared to your competitors
on overall Cx as well as at
channel level?

18. 25/11/2022
Proprietary and Confidential Information
© Across Health
18
Proprietary and confidential information
© Across Health
18
25/11/2022
Source:
When it comes to overall Cx at company level, as measured by the Customer
Effort Score (CES), Pfizer and GSK are in the lead Learn more about Navigator365™ Payer

19. 25/11/2022
Proprietary and Confidential Information
© Across Health
19 19
CASE STUDY
Not for external distribution.
© Across Health NV, All rights reserved.
Proprietary and confidential information 19
© Across Health
25/11/2022
“Omnichannel for payers:
an OCE payer strategy for EU4, UK & Canada”
Version 1.1
NEURO
Therapeutic area
CONVERT
Funnel phase
Watch our recorded webinar or get
access to the full slide deck

20. Proprietary and confidential information
© Across Health
20
25/11/2022
Proprietary and confidential information
© Across Health
20
25/11/2022
Want to understand more about payers in your market?
Want to learn more?
Pick up the phone
or drop us an email
Jason.cunningham@a-cross.com
+44 7841 753 830
David.ziedman@a-cross.com
+31 6 14 602 444
Learn more about Navigator365™

21. Proprietary and confidential information
© Across Health
21
25/11/2022
Proprietary and confidential information
© Across Health 21
25/11/2022
Want to know more? Check out our recorded webinars… and much more
Past events & recorded webinars
Across Health Resources

22. Proprietary and confidential information
© Across Health
22
25/11/2022
Proprietary and confidential information
© Across Health 22
25/11/2022
For more info,
contact us!
Watch the recorded webinar
and access the full deck here.
Thank you!